STSA   $1.1  -2.70% Market Closed

Satsuma Pharmaceuticals Inc
Last Events:

2023-07-18 Trend pattern changed from расходящийся треугольник to симметричный треугольник.

2023-07-18 Signal in Stochastic changed from bearish weakening to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: main and signal line crossing.

2023-05-20 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2023-05-20 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-05-19 Signal in Stochastic changed from bearish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: signal line crossed the middle level.

2023-05-19 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-05-18 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

2023-05-18 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.


Current temperature: 1.64
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.39
Target: 2.00
High with 50% probability: 1.96
Analyst Recommendations:
Number of estimates 3
Target Price Mean 2.00
Mean unverified/preliminary 2.00 / 2.00
Target Price Low / High 1.00 / 3.00
Median / STD DEV 2.00 / 1.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi Sell Sell -
macd Sell - -
stoch Sell - -
ma20 ActivelyBuy ActivelyBuy -
ma50 Sell - -
ma100 Sell Sell -
Candlestick PatternMarch 31, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US80405P1075
ceo Mr. John A. Kollins MBA
Website https://www.satsumarx.com
Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. As of June 8, 2023, Satsuma Pharmaceuticals, Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd.